The Food and Drug Administration says it approved a drug to reduce dangerous levels of a certain chemotherapy drug in cancer patients with failing kidneys.
The new drug from BTG International Inc. breaks up a chemotherapy drug called methotrexate so that it can be eliminated from the body.
Methotrexate can be harmful if it builds up in the body, causing liver and kidney damage, rashes and damage to the intestines.
On average, patients taking the drug, Voraxaze, eliminated 95 percent of the methotrexate in their system, according to the study used to support FDA approval. The most common side effects associated with the drug were low blood pressure, headache, nausea and vomiting.
BTG International is based in West Conshohocken, Pa.
Hillary to Ed Henry: You’re only entitled to ask me one question - Hot Air
Katie Pavlich - Carly Fiorina Responds to Hillary's Comparison of Republicans to Terrorists
Report: FBI 'A-team' investigating Hillary Clinton for possible violation of the Espionage Act
Two Impossible Things That Could Happen in 2016 | Human Events
Republican Party, R.I.P. (1854 - 2016) | RedState
Nick Adams - Not a Single Illegal Immigrant in 7 Months... In Australia
Vox "Smart Take" Pushes Gun Confiscation. Here's What Would Happen If They Tried. - Bearing Arms - 2nd Amendment, Gun Confiscation